	A viral aetiology for multiple sclerosis: In pursuit of Kurtzke's dark horse. Mult Scler Relat Disord Sutton I, Massey J. PMID: 42580010 [PubMed - as supplied by publisher]
	FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab. Neurol Neuroimmunol Neuroinflamm Abbadessa G, Chianese U, Russo C, Miele G, Maida E, Esposito G, Romano G, Bile F, Signoriello E, Lus G, Lavorgna L, Nicholas RS, Altucci L, Procaccini C, Matarese G, Benedetti R, Bonavita S. PMID: 42579840 [PubMed - indexed for MEDLINE]
	Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model. Health Technol Assess Manzano CL, Sadek A, Cooper C, Tomlinson E, Wang H, Rice C, Tallantyre E, Rao-Middleton A, Whiting P, Thom H. PMID: 42579606 [PubMed - indexed for MEDLINE]
	Advanced MRI in Multiple Sclerosis: Clinical Translation of Imaging Biomarkers in the 2024 McDonald Criteria. Radiology Michaelson NM, Buathong S, Treaba CA, Mayfield JD, Bhatt A, Mainero C, Klawiter EC, Huang SY. PMID: 42578789 [PubMed - indexed for MEDLINE]
	Protective effect of Glycyrrhizin on cuprizone-induced model of multiple sclerosis in male C57BL/6 mice. IBRO Neurosci Rep Morakkabi AS, Hassanpour S, Hosseini R. PMID: 42576952 [PubMed]
	Emergency department use before multiple sclerosis: Presenting complaints and discharge diagnoses. Mult Scler Ruiz-Algueró M, Zhu F, Zhao Y, Amini F, Marrie RA, Tremlett H. PMID: 42576404 [PubMed - as supplied by publisher]
	Associations between lifestyle factors and 2.5-year clinical outcomes differ by time since multiple sclerosis diagnosis. Neurol Sci Yu M, Jelinek G, Nag N. PMID: 42573837 [PubMed - indexed for MEDLINE]
	Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic review. Brain Res Vakilipour P, Sadigh-Eteghad S, Naseri A, Bonabi MA. PMID: 42571841 [PubMed - as supplied by publisher]
	Effectiveness of a digital health application (levidex) on quality of life in people with multiple sclerosis: A pragmatic, randomized controlled trial (LAMONT). Mult Scler J Exp Transl Clin Meyer B, Nelles G, Betz L, Bergmann A, Jauch-Chara K, Krause N, Riemann K, von Glasenapp B, Heesen C. PMID: 42571145 [PubMed]
	Corrigendum to "Diagnostic delay in patients with myelin oligodendrocyte antibody-associated disease presenting with elevated intracranial pressure" [Multiple Sclerosis and Related Disorders, Volume 112, August 2026, 107335]. Mult Scler Relat Disord Lakusta-Wong TM, Wysong KE, Solomon AJ. PMID: 42570877 [PubMed - in process]
	Selective taste impairment in relapsing-remitting Multiple Sclerosis and Supervised Learning - driven diagnostic classification. Mult Scler Relat Disord Melis M, Naciri LC, Mastinu M, Deligia S, Diana D, Idini E, Coghe G, Frau J, Crnjar R, Sollai G, Cocco E, Tomassini Barbarossa I. PMID: 42570510 [PubMed - as supplied by publisher]
	Mapping the immune-genetic architecture of Epstein-Barr virus-related phenotypes and multiple sclerosis through a single-cell genetic framework for target prioritization and pharmacologic hypothesis generation. Mult Scler Relat Disord Zhou Y, Huang X, She X, Hao Q, Mi Z, Yang Y. PMID: 42570508 [PubMed - as supplied by publisher]
	French expert opinion on the long-term management of relapsing multiple sclerosis with cladribine tablets beyond year 4. J Neurol Ricigliano VAG, Ciron J, Bourre B, Guennoc AM, Castelnovo G, Deschamps J, Payet M, Clavelou P, Vermersch P, de Seze J, Ayrignac X. PMID: 42552266 [PubMed - indexed for MEDLINE]
	Perspectives of participating neurologists and study nurses - Mixed-methods process evaluation of a web-based program for relapse management in multiple sclerosis (POWER@M2). Mult Scler Relat Disord Bremer L, Hickstein J, Wenzel L, Scheiderbauer J, de Loo MV, Rahn AC, Heesen C, Köpke S. PMID: 42551285 [PubMed - as supplied by publisher]
	Leveraging chimeric antigen receptor-T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology. Curr Res Transl Med Sanoyeva M, Nasirdinova N, Gulova M, Ortikova N, Yumashev A, Tolmasov R, Kholdarov T, Gardanova ZR. PMID: 42570396 [PubMed - as supplied by publisher]
	Understanding the family planning experiences and information needs of people living with multiple sclerosis: an Australian cohort study. Disabil Rehabil Fragkoudi A, Rumbold A, Thapaliya K, Laslett L, van der Mei I, Grzeskowiak L. PMID: 42569929 [PubMed - as supplied by publisher]
	Colorectal cancer screening in individuals with multiple sclerosis: A mixed-methods study. Mult Scler Pierret C, Bouvier R, Kerbrat S, Leray E. PMID: 42565361 [PubMed - as supplied by publisher]
	Disproportionate pace of evidence-based care implementation in pediatric-onset multiple sclerosis: consequences and opportunities. Implement Sci Commun Gambrah-Lyles C, Cole JJ, Ramsey AT. PMID: 42563200 [PubMed]
	Neurogenic bladder in the multiple sclerosis population: A systematic review and meta-analysis of prevalence and a proposed evaluation algorithm. Neurol Sci Giannopapas V, Dimitriadou EM, Kitsos DK, Akrivaki A, Stefanou MI, Stavrogianni K, Chasiotis AK, Tzartos JS, Bakalidou D, Tsivgoulis G, Paraskevas GP, Tsamis K, Giannopoulos S. PMID: 42563020 [PubMed - indexed for MEDLINE]
	Retinal layers prognosticate cognitive progression independent of relapse activity in multiple sclerosis. J Neurol Cerdá-Fuertes N, Sankar S, Pless S, Stoessel M, Sellathurai S, Schoenholzer K, Burguet Villena F, Cagol A, Hofer L, Demirtzoglou A, Fischer-Barnicol B, Calabrese P, Benkert P, Müller J, D'Souza M, Gugleta K, Derfuss T, Granziera C, Kappos L, Kuhle J, Papadopoulou A. PMID: 42562954 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 44657

Page 1 of 2233



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy